Atlas Trials

Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast Cancer

Clinical trial NCT03457467 · UNKNOWN

Trial details

NCT number
NCT03457467
Sponsor
Yan Li
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2018-03-15
Primary completion
2019-03-15
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.